ST6GAL1 and prostate carcinoma: Next, using immunohistochemistry (IHC) we analysed ST6GAL1 levels in a 96 case tissue microarray (TMA) comprising tissue from patients with prostate cancer diagnosed with tumours of different Gleason grades.26